Comparison of the bronchodilator and cardiac effects of hydroxyphenylorciprenaline and orciprenaline

Chest. 1974 May;65(5):507-11. doi: 10.1378/chest.65.5.507.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Asthma / drug therapy*
  • Bronchi / drug effects*
  • Bronchodilator Agents / pharmacology*
  • Clinical Trials as Topic
  • Female
  • Heart / drug effects*
  • Heart Rate / drug effects
  • Humans
  • Male
  • Metaproterenol / administration & dosage
  • Metaproterenol / adverse effects
  • Metaproterenol / pharmacology
  • Metaproterenol / therapeutic use*
  • Middle Aged
  • Phenols / adverse effects
  • Phenols / pharmacology
  • Pulmonary Ventilation / drug effects
  • Respiration / drug effects*
  • Respiratory Therapy
  • Tachycardia / chemically induced
  • Vital Capacity / drug effects

Substances

  • Bronchodilator Agents
  • Phenols
  • Metaproterenol